| scholarly article | Q13442814 |
| P50 | author | Ju Hyun Shin | Q83001845 |
| Gun-Hwa Kim | Q89299109 | ||
| Yong Gil Na | Q91102495 | ||
| Edmond Changkyun Park | Q91948307 | ||
| P2093 | author name string | Seung Il Kim | |
| Hyo Kyun Chung | |||
| Koon Soon Kim | |||
| Joohyun Park | |||
| Jae Sung Lim | |||
| Sungho Yun | |||
| Chi-Won Choi | |||
| Minji Lee | |||
| Sang-Yeop Lee | |||
| Yu-Kyung Tak | |||
| P2860 | cites work | Pathophysiology of the urothelium and detrusor | Q38705964 |
| The Biology of Huntingtin. | Q38759081 | ||
| Activins and Inhibins: Roles in Development, Physiology, and Disease | Q38872337 | ||
| Long-term nitric oxide deficiency causes muscarinic supersensitivity and reduces beta(3)-adrenoceptor-mediated relaxation, causing rat detrusor overactivity | Q39516918 | ||
| Effects of retinol binding protein-4 on vascular endothelial cells | Q39566012 | ||
| Urothelial Dysfunction and Chronic Inflammation in Diabetic Patients with Overactive Bladder | Q39885791 | ||
| Structure and function of the anaphylatoxins | Q40190947 | ||
| A myogenic basis for the overactive bladder | Q41679687 | ||
| In vitro release of adenosine triphosphate from the urothelium of human bladders with detrusor overactivity, both neurogenic and idiopathic | Q42464635 | ||
| Identification of anti-inflammatory targets for Huntington's disease using a brain slice-based screening assay | Q42741104 | ||
| Association of inflammaging (inflammation + aging) with higher prevalence of OAB in elderly population | Q46961530 | ||
| C3a modulates IL-1β secretion in human monocytes by regulating ATP efflux and subsequent NLRP3 inflammasome activation. | Q47954758 | ||
| Urodynamic characteristics of rats with detrusor instability. | Q51073021 | ||
| Novel mouse model of chronic inflammatory and overactive bladder by a single intravesical injection of hydrogen peroxide. | Q51254647 | ||
| Preventive Effect of Hydrogen Water on the Development of Detrusor Overactivity in a Rat Model of Bladder Outlet Obstruction. | Q51665464 | ||
| Simultaneous registration of intraabdominal and intravesical pressures during cystometry in conscious rats--effects of bladder outlet obstruction and intravesical PGE2. | Q51750367 | ||
| Age and bladder outlet obstruction are independently associated with detrusor overactivity in patients with benign prostatic hyperplasia. | Q51891457 | ||
| Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. | Q53248115 | ||
| The standardisation of terminology of lower urinary tract function: report from the Standardisation Sub-committee of the International Continence Society. | Q53317478 | ||
| Muscarinic and purinergic receptor expression in the urothelium of rats with detrusor overactivity induced by bladder outlet obstruction. | Q53560461 | ||
| Effects of intravesical instillation of cyclooxygenase-2 inhibitor on the expression of inducible nitric oxide synthase and nerve growth factor in cyclophosphamide-induced overactive bladder. | Q53591680 | ||
| Loss of dicer exacerbates cyclophosphamide-induced bladder overactivity by enhancing purinergic signaling. | Q54300894 | ||
| Modulating bladder neuro-inflammation: RDP58, a novel anti-inflammatory peptide, decreases inflammation and nerve growth factor production in experimental cystitis. | Q54493231 | ||
| ATP is released from rabbit urinary bladder epithelial cells by hydrostatic pressure changes--a possible sensory mechanism? | Q74017496 | ||
| Experimental bladder instability following bladder outlet obstruction in the female rat | Q77562440 | ||
| Drug therapy of overactive bladder--what is coming next? | Q26780197 | ||
| Evidence for bladder urothelial pathophysiology in functional bladder disorders | Q26824708 | ||
| How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study | Q28202479 | ||
| SNARE function analyzed in synaptobrevin/VAMP knockout mice | Q28203549 | ||
| Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein | Q29617305 | ||
| Overexpression of NGF in mouse urothelium leads to neuronal hyperinnervation, pelvic sensitivity, and changes in urinary bladder function. | Q33728157 | ||
| Role of inflammation in bladder function and interstitial cystitis | Q34203459 | ||
| Mitochondrial ATP synthase: architecture, function and pathology. | Q34211463 | ||
| ADP-induced bladder contractility is mediated by P2Y12 receptor and temporally regulated by ectonucleotidases and adenosine signaling | Q34512888 | ||
| The Role of the Mucosa in Normal and Abnormal Bladder Function | Q34528370 | ||
| Prevalence and burden of overactive bladder in the United States | Q34534593 | ||
| Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade | Q34756092 | ||
| Role of Purinergic Signaling in Voiding Dysfunction | Q34973917 | ||
| Mechanisms of disease: involvement of the urothelium in bladder dysfunction | Q35057494 | ||
| Retinol-binding protein 4 levels and susceptibility to ischaemic events in men. | Q35144562 | ||
| Analysis of the endoplasmic reticulum subproteome in the livers of type 2 diabetic mice | Q36538589 | ||
| Complement in immune and inflammatory disorders: pathophysiological mechanisms | Q36756850 | ||
| Physiology and pathophysiology of purinergic neurotransmission | Q36788894 | ||
| Development of an Improved Animal Model of Overactive Bladder: Transperineal Ligation versus Transperitoneal Ligation in Male Rats | Q37208238 | ||
| Chronic pelvic pain syndrome and the overactive bladder: the inflammatory link | Q37258893 | ||
| A refocus on the bladder as the originator of storage lower urinary tract symptoms: a systematic review of the latest literature | Q37580537 | ||
| Animal models in overactive bladder research. | Q37835057 | ||
| Biomarkers in overactive bladder | Q38073581 | ||
| Biomarkers in lower urinary tract symptoms/overactive bladder: a critical overview | Q38212859 | ||
| Therapeutic targets for overactive bladder other than smooth muscle | Q38364035 | ||
| A method for extracting tissue proteins for use in lymphocyte function assays | Q38485459 | ||
| The Current Indications and the Benefits of Combining a β3-Agonist with an Anticholinergic for the Treatment of OAB. | Q38561322 | ||
| Overactive Bladder and the β3-Adrenoceptor Agonists: Current Strategy and Future Prospects | Q38577301 | ||
| Emerging drugs for overactive bladder | Q38584641 | ||
| P433 | issue | 5 | |
| P304 | page(s) | 948-960 | |
| P577 | publication date | 2018-02-01 | |
| P1433 | published in | Molecular & Cellular Proteomics | Q6895932 |
| P1476 | title | Proteomic analysis of urothelium of rats with detrusor overactivity induced by bladder outlet obstruction | |
| P478 | volume | 17 |
| Q92512568 | A non-enzymatic method for dissection of mouse bladder urothelial tissue | cites work | P2860 |
Search more.